Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study
Author:
Affiliation:
1. IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna Italy
2. Dipartimento di Scienze Biomediche e NeuroMotorie Università degli Studi di Bologna Bologna Italy
3. Azienda USL di Bologna Bologna Italy
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15505
Reference53 articles.
1. An interactive web-based dashboard to track COVID-19 in real time
2. COVID-19 and Parkinson’s Disease: What Do We Know So Far?
3. Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)
4. COVID-19 related outcomes among individuals with neurodegenerative diseases: a cohort analysis in the UK biobank
5. Effects of COVID ‐19 on Parkinson's Disease Clinical Features: A Community‐Based Case‐Control Study
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain;European Journal of Neurology;2024-09-06
2. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration;Molecular Neurodegeneration;2024-04-19
3. Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment;Frontiers in Neurology;2024-04-04
4. Deciphering the molecular pathways underlying dopaminergic neuronal damage in Parkinson's disease associated with SARS-CoV-2 infection;Computers in Biology and Medicine;2024-03
5. Life and disease status of patients with Parkinson’s disease during and after zero-COVID in China: an online survey;Translational Neurodegeneration;2024-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3